article thumbnail

Navigating tariffs and diplomacy: the future of India-US pharmaceutical trade

Pharmaceutical Technology

Go deeper with GlobalData Reports Future of Pharma - Looking Ahead to 2023 Reports China Contract Manufacturing Market Outlook - Trends, Ambitions, Ke. If successful, India will become the first country to sign a bilateral trade agreement (BTA) of such with the US during President Trump’s second term in the White House.

article thumbnail

CHMP meeting highlights – January 2023

European Pharmaceutical Review

In its first meeting of 2023, the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) recommended four new medicines for approval, providing positive opinions for two type 2 diabetes drugs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What a mild recession could mean for small biotechs in 2023

Pharmaceutical Technology

in 2022 to 1% in 2023 due to the “tightening of monetary and financial conditions”. Furthermore, for months, several financial institutions such as Bank of America and JP Morgan have been talking of a “mild recession” in 2023 for the US. by the end of 2023 and may continue to rise in 2024 to 5%.

article thumbnail

Inflation threatens supply of life-saving generics to Europe

Pharmaceutical Technology

The EU has banned the export of crude oil (from December 2022) and refined petroleum products (from February 2023), as well as coal and other solid fossil fuels. Europe also enforces rigid pricing policies for essential medicines to be available at the lowest possible price.

article thumbnail

CHMP meeting highlights: January 2024

European Pharmaceutical Review

Ryzneuta (efbemalenograstim alfa) received a positive opinion from the CHMP as a medicine to reduce the duration of neutropenia and the incidence of febrile neutropenia due to chemotherapy. Additionally, a positive opinion for Niapelf (paliperidone), a generic medicine for schizophrenia was adopted in the meeting.

article thumbnail

Parallel import of medicinal products: regulatory update

European Pharmaceutical Review

The CJEU stressed that identical medicinal products are not those that are only therapeutically equivalent (as generics are to reference products), but they should be identical in all respects.

article thumbnail

Small molecule API market to value $284.7 billion by 2032

European Pharmaceutical Review

percent during the forecast period from 2023 to 2032 is predicted. The small molecule API market is influenced by several factors, including heightened R&D within the pharmaceutical sector, a growing prevalence of chronic illnesses and rising demand for generic medicines. A compound annual growth rate (CAGR) growth of 5.9